Profusa, Inc. Common Stock

Profusa completed a merger with NorthView Acquisition Corporation, reduced net debt to $14 million, and is preparing to launch its Lumee Oxygen tissue monitoring platform in Europe in early 2026, with potential revenue targets of $0.5-$2 million in 2026 and $9-$13 million in 2027.